Literature DB >> 31352528

Electrical Storm: Current Evidence, Clinical Implications, and Future Perspectives.

Christos Kontogiannis1, Konstantinos Tampakis2,3, Georgios Georgiopoulos2, Stefano Bartoletti3, Christos Papageorgiou2, Hector Anninos2, Alkistis Kapelouzou4, Michael Spartalis4, Ioannis Paraskevaidis2, Sofia Chatzidou2.   

Abstract

PURPOSE OF REVIEW: Electrical storm (ES) is a life-threatening medical emergency of repetitive episodes of sustained ventricular arrhythmias within a short period. Its occurrence is associated with poor short- and long-term survival, even in patients with implantable cardioverter defibrillators (ICD). Management of ES is challenging and mainly based on retrospective studies. This article reviews the existing literature on ES, presents the available data regarding its management, and proposes a new algorithm based on current evidence. RECENT
FINDINGS: Recent research could modify the management of ES supporting the role of non-selective β1 and β2 blockade and the early intervention with catheter ablation as well as strengthening the role of cardiac sympathetic denervation. A multipronged approach should be considered for the management of ES including identification and correction of reversible causes, ICD reprogramming, drug therapy (beta-blockers-especially non-selective ones-and other anti-arrhythmic drugs) and non-pharmacologic therapies such as catheter ablation and techniques of neuroaxial modulation. Although current data suggest early aggressive management, further research is required to clarify the optimal order and combination of therapies for the prevention of future events.

Entities:  

Keywords:  Beta-blockers; Electrical storm; Implantable cardioverter defibrillator; Recurrent ventricular tachycardia; Ventricular arrhythmias

Mesh:

Substances:

Year:  2019        PMID: 31352528     DOI: 10.1007/s11886-019-1190-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  58 in total

Review 1.  Ventricular tachycardia syndromes.

Authors:  W I Saliba; A Natale
Journal:  Med Clin North Am       Date:  2001-03       Impact factor: 5.456

2.  Propofol for electrical storm; a case report of cardioversion and suppression of ventricular tachycardia by propofol.

Authors:  Jessica E Burjorjee; Brian Milne
Journal:  Can J Anaesth       Date:  2002-11       Impact factor: 5.063

3.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

4.  Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.

Authors:  A Pacifico; S H Hohnloser; J H Williams; B Tao; S Saksena; P D Henry; E N Prystowsky
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

5.  Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation.

Authors:  L Brent Mitchell; Edgar A Pineda; Jack L Titus; Paulette M Bartosch; David G Benditt
Journal:  J Am Coll Cardiol       Date:  2002-04-17       Impact factor: 24.094

6.  Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II).

Authors:  William N Brodine; Robert T Tung; John K Lee; Eric S Hockstad; Arthur J Moss; Wojciech Zareba; W Jackson Hall; Mark Andrews; Scott McNitt; James P Daubert
Journal:  Am J Cardiol       Date:  2005-09-01       Impact factor: 2.778

7.  Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy.

Authors:  K Nademanee; R Taylor; W E Bailey; D E Rieders; E M Kosar
Journal:  Circulation       Date:  2000-08-15       Impact factor: 29.690

8.  Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.

Authors:  Mark S Wathen; Paul J DeGroot; Michael O Sweeney; Alice J Stark; Mary F Otterness; Wayne O Adkisson; Robert C Canby; Koroush Khalighi; Christian Machado; Donald S Rubenstein; Kent J Volosin
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

9.  Efficacy of metoprolol and sotalol in the prevention of recurrences of sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.

Authors:  Klaus Kettering; Christian Mewis; Volker Dörnberger; Reinhard Vonthein; Ralph F Bosch; Volker Kühlkamp
Journal:  Pacing Clin Electrophysiol       Date:  2002-11       Impact factor: 1.976

10.  Effects of chronic amiodarone therapy on defibrillation threshold.

Authors:  W Jung; M Manz; L Pizzulli; D Pfeiffer; B Lüderitz
Journal:  Am J Cardiol       Date:  1992-10-15       Impact factor: 2.778

View more
  3 in total

1.  Effective treatment of electrical storm by a wearable cardioverter defibrillator in a patient with severely impaired left ventricular function after myocardial infarction: a case report.

Authors:  Henrike Andresen; B Sasko; D Patschan; N Pagonas; O Ritter
Journal:  J Med Case Rep       Date:  2021-05-17

Review 2.  Contemporary ICD Use in Patients with Heart Failure.

Authors:  Michael Spartalis; Kenzaburo Nakajima; David Zweiker; Eleftherios Spartalis; Dimitrios C Iliopoulos; Gerasimos Siasos
Journal:  Cardiol Ther       Date:  2021-06-15

Review 3.  The efficacy of catheter ablation versus ICD for prevention of ventricular tachycardia in patients with ischemic heart disease: a systematic review and meta-analysis.

Authors:  Guolin Liu; Xin Xu; Qijian Yi; Tiewei Lv
Journal:  J Interv Card Electrophysiol       Date:  2021-03-15       Impact factor: 1.900

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.